• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症和神经退行性血清蛋白生物标志物可提高检测多发性硬化症疾病活动的敏感性。

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis.

作者信息

Chitnis Tanuja, Qureshi Ferhan, Gehman Victor M, Becich Michael, Bove Riley, Cree Bruce A C, Gomez Refujia, Hauser Stephen L, Henry Roland G, Katrib Amal, Lokhande Hrishikesh, Paul Anu, Caillier Stacy J, Santaniello Adam, Sattarnezhad Neda, Saxena Shrishti, Weiner Howard, Yano Hajime, Baranzini Sergio E

出版信息

medRxiv. 2023 Jul 3:2023.06.28.23291157. doi: 10.1101/2023.06.28.23291157.

DOI:10.1101/2023.06.28.23291157
PMID:37461671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10350151/
Abstract

BACKGROUND/OBJECTIVES: Serum proteomic analysis of deeply-phenotyped samples, biological pathway modeling and network analysis were performed to elucidate the inflammatory and neurodegenerative processes of multiple sclerosis (MS) and identify sensitive biomarkers of MS disease activity (DA).

METHODS

Over 1100 serum proteins were evaluated in >600 samples from three MS cohorts to identify biomarkers of clinical and radiographic (gadolinium-enhancing lesions) new MS DA. Protein levels were analyzed and associated with presence of gadolinium-enhancing lesions, clinical relapse status (CRS), and annualized relapse rate (ARR) to create a custom assay panel.

RESULTS

Twenty proteins were associated with increased clinical and radiographic MS DA. Serum neurofilament light chain (NfL) showed the strongest univariate correlation with radiographic and clinical DA measures. Multivariate modeling significantly outperformed univariate NfL to predict gadolinium lesion activity, CRS and ARR.

DISCUSSION

These findings provide insight regarding correlations between inflammatory and neurodegenerative biomarkers and clinical and radiographic MS DA.

FUNDING

Octave Bioscience, Inc (Menlo Park, CA).

摘要

背景/目的:对深度表型样本进行血清蛋白质组分析、生物通路建模和网络分析,以阐明多发性硬化症(MS)的炎症和神经退行性变过程,并识别MS疾病活动(DA)的敏感生物标志物。

方法

在来自三个MS队列的600多个样本中评估了1100多种血清蛋白,以识别临床和影像学(钆增强病灶)新发MS DA的生物标志物。分析蛋白水平,并将其与钆增强病灶的存在、临床复发状态(CRS)和年化复发率(ARR)相关联,以创建一个定制检测面板。

结果

20种蛋白与临床和影像学MS DA增加相关。血清神经丝轻链(NfL)与影像学和临床DA指标的单变量相关性最强。多变量建模在预测钆病灶活动、CRS和ARR方面显著优于单变量NfL。

讨论

这些发现为炎症和神经退行性生物标志物与临床和影像学MS DA之间的相关性提供了见解。

资金来源

奥克塔夫生物科学公司(加利福尼亚州门洛帕克)

相似文献

1
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis.炎症和神经退行性血清蛋白生物标志物可提高检测多发性硬化症疾病活动的敏感性。
medRxiv. 2023 Jul 3:2023.06.28.23291157. doi: 10.1101/2023.06.28.23291157.
2
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.炎症和神经退行性血清蛋白生物标志物可提高多发性硬化症临床和影像学疾病活动的检测灵敏度。
Nat Commun. 2024 May 20;15(1):4297. doi: 10.1038/s41467-024-48602-9.
3
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.脑脊液神经丝轻链蛋白与几丁质酶-3样蛋白1联合检测在多发性硬化症疾病进程及预后判断中的应用
Front Neurol. 2019 Sep 23;10:1008. doi: 10.3389/fneur.2019.01008. eCollection 2019.
4
Relevance of dedicated multiple sclerosis serum biomarkers in predicting contrast enhancement with gadolinium: Results from the REDUCE-GAD trial.专用多发性硬化症血清生物标志物在预测钆增强中的相关性:来自 REDUCE-GAD 试验的结果。
Eur J Neurol. 2023 Aug;30(8):2393-2400. doi: 10.1111/ene.15865. Epub 2023 May 29.
5
Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.多发性硬化症(MS)队列中的神经胶质和神经轴突生物标志物
Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:113-121.
6
Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis.多发性硬化症疾病活动评估的基于多种蛋白质的血清检测的临床验证。
Clin Immunol. 2023 Aug;253:109688. doi: 10.1016/j.clim.2023.109688. Epub 2023 Jul 4.
7
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes.血清神经丝在临床孤立综合征患者中的预后价值。
Neurology. 2019 Feb 12;92(7):e733-e741. doi: 10.1212/WNL.0000000000006902. Epub 2019 Jan 11.
8
Serum neurofilament light as a biomarker in progressive multiple sclerosis.血清神经丝轻链作为进展性多发性硬化症的生物标志物。
Neurology. 2020 Sep 8;95(10):436-444. doi: 10.1212/WNL.0000000000010346. Epub 2020 Jul 16.
9
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management.神经丝轻链作为多发性硬化症管理中脑脊液和血液生物标志物的使用指南。
EBioMedicine. 2024 Mar;101:104970. doi: 10.1016/j.ebiom.2024.104970. Epub 2024 Feb 13.
10
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.在临床孤立综合征和血清 NfL、GFAP 和金属蛋白酶水平中使用米诺环素治疗。
Mult Scler. 2022 Nov;28(13):2081-2089. doi: 10.1177/13524585221109761. Epub 2022 Jul 18.